Novo Nord plans to invest 2.3 billion U.S. dollars to expand its plant in Denmark. Novo Nord, a Danish pharmaceutical company, plans to invest 15.9 billion Danish kroner (about 2.3 billion U.S. dollars) in Denmark to expand production and provide greater production capacity for its future product portfolio to cope with the growing demand for treatment.